Search Results - "Robertson, L.E."

Long-Term Follow-Up of Patients With Chronic Lymphocytic Leukemia (CLL) Receiving Fludarabine Regimens as Initial Therapy by Keating, M.J., O’Brien, S., Lerner, S., Koller, C., Beran, M., Robertson, L.E., Freireich, E. J, Estey, E., Kantarjian, H.

“…One hundred seventy-four patients with progressive or advanced chronic lymphocytic leukemia (CLL) have received initial therapy with fludarabine as a single…”
Get full text

Induction of Apoptotic Cell Death in Chronic Lymphocytic Leukemia by 2-Chloro-2′-deoxyadenosine and 9-β-D-Arabinosyl-2-fluoroadenine by Robertson, L.E., Chubb, Sherri, Meyn, Raymond E., Story, Michael, Ford, Richard, Hittelman, Walter N., Plunkett, William

“…2-Chloro-2′-deoxyadenosine (CldAdo) and 9-β-D-arabinosyl-2-fluoroadenine (F-ara-A) have shown marked activity in the treatment of indolent lymphoid…”
Get full text

Homoharringtonine Therapy Induces Responses in Patients With Chronic Myelogenous Leukemia in Late Chronic Phase by O'Brien, Susan, Kantarjian, Hagop, Keating, Michael, Beran, Miloslav, Koller, Charles, Robertson, L.E., Hester, Jeane, Rios, MaryBeth, Andreeff, Michael, Talpaz, Moshe

“…Homoharringtonine (HHT) is a plant alkaloid with potent myelosuppressive activity and little toxicity when used in a continuous infusion schedule. The…”
Get full text

Implications of apoptotic cell death regulation in cancer therapy by McDonnell, Timothy J., Meyn, Raymond E., Robertson, L.E.

“…The process of programmed cell death, or apoptosis, is now recognized as an important component of multistep carcinogenesis. Traditionally, interventions used…”
Get full text

Response Assessment in Chronic Lymphocytic Leukemia After Fludarabine Plus Prednisone: Clinical, Pathologic, Immunophenotypic, and Molecular Analysis by Robertson, L.E., Huh, Yang O., Butler, James J., Pugh, William C., Cheryl, Hirsch-Ginsberg, Sanford, Stass, Kantarjian, Hagop, Michael, Keating J.

“…The goals of this study were to evaluate the response to treatment in chronic lymphocytic leukemia (CLL) according to clinical, pathologic, immunophenotypic,…”
Get full text

Long-Term Follow-Up of Patients With Chronic Lymphocytic Leukemia (CLL) Receiving Fludarabine Regimens as Initial Therapy by Keating, M.J., O'Brien, S., Lerner, S., Koller, C., Beran, M., Robertson, L.E., Freireich, E. J, Estey, E., Kantarjian, H.

“…One hundred seventy-four patients with progressive or advanced chronic lymphocytic leukemia (CLL) have received initial therapy with fludarabine as a single…”
Get full text

The role of fludarabine in hematological malignancies by Wright, S J, Robertson, L E, O'Brien, S, Plunkett, W, Keating, M J

“…Fludarabine monophosphate, a synthetic nucleoside analog, has been shown to have considerable activity in a number of lymphoid malignancies. In chronic…”
Get more information

Fluorescence In Situ Hybridization Identifies Inversion 16 Masked by t(10;16)(q24;q22), t(7;16)(q21;q22), and t(2;16)(q37;q22) in Three Cases of AML-M4Eo by Reddy, K.S., Wang, S., Montgomery, P., Grove, W., Robertson, L.E.

“…Bone marrow or peripheral blood from three patients had a t(10;16)(q24;q22), t(7;16)(q21;p13.1), and t(2;16)q37;q22), respectively. In all cases, fluorescence…”
Get full text